After the 2022 Dobbs decision, the anti-abortion movement’s sights are now set on medication abortion
Dozens of anti-abortion activists streamed into the conference room of a Washington DC hotel. They jostled for seats as speakers, dotted throughout the room, blasted a song about the need to be “a little more like Jesus, a little less like me”.
By the time a trio of advocates, assembled on a dais at the front of the room, started to talk about the “Future of Chemical Abortion in America”, the title of one of the first seminars at the National Pro-Life Summit, it was standing room only.